<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.2d1 20170631//EN" "JATS-journalpublishing1.dtd">
<article xlink="http://www.w3.org/1999/xlink" dtd-version="1.0" article-type="healthcare" lang="en"><front><journal-meta><journal-id journal-id-type="publisher">IJCRR</journal-id><journal-id journal-id-type="nlm-ta">I Journ Cur Res Re</journal-id><journal-title-group><journal-title>International Journal of Current Research and Review</journal-title><abbrev-journal-title abbrev-type="pubmed">I Journ Cur Res Re</abbrev-journal-title></journal-title-group><issn pub-type="ppub">2231-2196</issn><issn pub-type="opub">0975-5241</issn><publisher><publisher-name>Radiance Research Academy</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">463</article-id><article-id pub-id-type="doi"/><article-id pub-id-type="doi-url"/><article-categories><subj-group subj-group-type="heading"><subject>Healthcare</subject></subj-group></article-categories><title-group><article-title>HEPATITIS C VIRUS: SCREENING, DIAGNOSIS, AND INTERPRETATION OF LABORATORY ASSAYS&#13;
</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Agravat</surname><given-names>Amit H.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Gamit</surname><given-names>Mital J.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Dhruva</surname><given-names>Gauravi A.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Bhojani</surname><given-names>Kaushal R.</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pujara</surname><given-names>Krupal M.</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>21</day><month>08</month><year>2015</year></pub-date><volume>)</volume><issue/><fpage>9</fpage><lpage>13</lpage><permissions><copyright-statement>This article is copyright of Popeye Publishing, 2009</copyright-statement><copyright-year>2009</copyright-year><license license-type="open-access" href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution (CC BY 4.0) Licence. You may share and adapt the material, but must give appropriate credit to the source, provide a link to the licence, and indicate if changes were made.</license-p></license></permissions><abstract><p>Background: All blood and blood products should be tested for Hepatitis C virus (HCV) before transfusion to decrease prevalence&#13;
of HCV.&#13;
Aim and Objective: The aim of present study is to determine the prevalence of hepatitis c virus (HCV) and to check the accuracy&#13;
of our laboratory analysis used for HCV testing of blood donors in our blood bank.&#13;
Material and Methods: The duration of this study is of 2 year since April 2013 to March 2015. All donors are screened during&#13;
counselling. The blood sample of Total Donor 26,789 including voluntary and replacement were tested for anti HCV antibody by&#13;
3 rd generation ELISA (QUALISA).Samples which are reactive or in gray zone were retested by ELISA and also confirmed by&#13;
rapid HCV card.&#13;
Results: From total donor 26,789, positive for the HCV were 45 (0.16%). Out of 45, 42 (93.3%) were male, 3(6.6 %,) were female&#13;
positive. 25 (55.5%) were voluntary and 20 (44.4%) were replacement. Maximum donors come under the age group of&#13;
21-30 and 31 -40 and 22 (48.8%) were B RhD positive subjects found.&#13;
Conclusion: The prevalence of HCV infection is mild (0.16 %) in blood donors in blood bank of PDU medical college and hospital,&#13;
Rajkot. The prevalence is equal in voluntary and replacement donors. Males are more infective than female.&#13;
</p></abstract><kwd-group><kwd>HCV infection</kwd><kwd> Anti HCV antibody</kwd><kwd> Blood donors</kwd></kwd-group></article-meta></front></article>
